Refractory cytopenia with multilineage dysplasia: Further characterization of an 'Unclassifiable' myelodysplastic syndrome

Leukemia

Volumn 10, Issue 1, 1996, Pages 20-26

  Rosati, S ^a   Mick, R ^b   Xu, F ^b   Stonys, E ^b   Le Beau, M M ^b   Larson, R ^b   Vardiman, J W ^b,c  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Myelodysplastic syndrome; Refractory anemia; Refractory cytopenia

Indexed keywords

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW; CELL HYPERPLASIA; CELL PROLIFERATION; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ERYTHROID CELL; FEMALE; HUMAN; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; NOMENCLATURE; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY CYTOPENIA WITH MULTILINEAR DYSPLASIA; SIDEROBLASTIC ANEMIA;

EID: 0030019452     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bennett JM et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Jacobs RH et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765-1772.
3. Gattermann N, Aul C, Schneider W. Two types of acquired sideroblastic anemia (AISA). Br J Haematol 1990; 74: 45-52.
4. Michels S, Chan W, Jakubowski D, Vogler R. Unclassifiable myelodysplastic syndrome: a study of sixteen cases with a proposal for a new subtype. Lab Invest 1990; 62: 67 (abstr.).
5. Brunning RD, McKenna RW. Myelodysplastic syndromes. In: Rosai J (ed). Atlas of Tumor Pathology, third series, Fascicle 9: Tumors of the Bone Marrow. Armed Forces Institute of Pathology: Washington DC, 1994, pp 161-168.
6. Van den Berghe H et al. Distinct haematological disorder with deletion of the long arm of no. 5 chromosome. Nature 1974; 251: 437-438.
7. Boultwood J, Lewis S, Wainscoat JS. The 5q- syndrome. Blood 1994; 84: 3253-3260.
8. Bennett JM et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
9. Cheson BD et al. Report of the National Cancer Institute-sponsored Workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 5: 813-819.
10. Nagai K et al. Remission with morphological myelodysplasia in de novo acute myeloid leukemia: implications for early relapse. Br J Haematol 1992; 81: 33-39.
11. Mufti GJ et al. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425-433.
12. JSCN (1991), Mitelman F (ed). Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel, 1991.
13. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Report of the Workshop held in Scottsdale, Arizona, USA, February 23-25, 1987. Cancer Genet Cytogenet 1988; 32: 1-10.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
16. Morel P et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315-1323.
17. Cazzola M et al. Natural history of idiopathic refractory sideroblastic anemia. Blood 1988; 71: 305-312.
18. Garand R et al. Heterogeneity of acquired idiopathic sideroblastic anemia (AISA). Leuk Res 1992; 16: 463-468.
19. Coiffier B et al. Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer 1983; 52: 83-90.
20. Sanz GF et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395-408.
21. Goasguen JE et al. Prognostic factors of myelodysplastic syndromes - a simplified 3-D scoring system. Leuk Res 1990; 14: 255-262
22. Aul C et al. Primary myelodysplastic syndromes, analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52-59.
23. Yunis JJ et al. Refined chromosome study helps to define prognostic groups in most patients with primary myelodysplastic syndromes and acute myelogenous leukemia. Br J Haematol 1988 68: 189-194.
24. Pierre RV et al. Chnical-cytogenetic correlations in myelodysplasia (preleukemia). From the Sixth International Workshop on Chromosomes in Leukemia, London, 1987. Cancer Genet Cytogenet 1989; 40: 149-161.
25. Geddes AD, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndromes. Br J Haematol 1990; 76: 194-202.
26. White AD, Culligan DJ, Hoy TG, Jacobs AJ. Extended cytogenetic follow-up of patients with myelodysplastic syndromes (MDS). Br J Haematol 1992; 81: 499-502.
27. Benitez J, Perez Rous G, Sanchez Fayos J. Prognostic value or complex karyotypes in patients with simple refractory anemia Cancer Genet Cytogenet 1991; 53: 279-280.
28. Toyama K et al. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993; 7: 499-508.
29. Janssen JWG et al. Clonal analysis of myelodysplastic syndromes, evidence of multipotent stem cell origin. Blood 1989; 73: 248-254.
30. Tsukamoto N et al. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993; 83: 589-594.
31. Raskind WH et al. Evidence for a multistep pathogenesis of a myelodysptastic syndrome. Blood 1984; 63: 1318-1323.
32. Anastasi J et al. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage. response to growth factor therapy and clone expansion. Blood 1993; 81: 1580-1585.
33. Olopade OI et al. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 1992; 80: 2873-2882.
34. Menke DM et al. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol 1992; 98: 502-510.